3rd Annual Drug Repositioning & R&D Enhancement 2010

Repositioning Through Scientific and Strategic Approaches and Optimizing the Product Life Cycle.

Delegates will benefit from more than 15 industry perspectives on scientific and strategic approaches to optimizing product life-cycle. With the recent passing of the health care bill and the future of biosimilar looming, this is a critical time for pharmaceutical, biotech and medical device companies to develop creative ways to extend the life-cycle of their products before they are replaced by their generic versions.

This conference will provide an opportunity for top-level executives to collaborate and work together with their peers to formulate the most effective scientific and commercial strategies to extend life-cycle management.